Best Zegfrovy (Sunvozertinib) Medicine in India

Zegfrovy (Sunvozertinib) is a targeted anticancer treatment used for adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations whose disease has progressed on or after platinum-based chemotherapy. It belongs to a group of medicines called kinase inhibitors and specifically targets abnormal EGFR signaling involved in cancer cell growth.

Zegfrovy (Sunvozertinib) should be taken exactly as prescribed by your doctor. It is taken by mouth with food and should be swallowed whole with water. Regular medical check-ups and tests may be required to monitor your response to treatment and detect potential side effects.

Common side effects of Zegfrovy (Sunvozertinib) may include rash, diarrhea, dry skin, nausea, decreased appetite, vomiting, muscle or joint pain, and changes in liver function tests. It may also cause serious lung inflammation, gastrointestinal problems, skin reactions, and eye-related problems. Inform your doctor promptly if you develop new or worsening breathing difficulties, severe diarrhea, significant skin reactions, or vision changes.

Treatment of EGFR Exon 20 Insertion-Positive NSCLC

Zegfrovy (Sunvozertinib) is used to treat adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations whose disease has progressed after platinum-based chemotherapy. It targets abnormal EGFR signaling, helping to slow cancer cell growth and progression.

Most side effects do not require medical attention and may improve as your body adjusts to the treatment. Consult your doctor if they persist, become severe, or cause concern.

Common Side Effects of Zegfrovy (Sunvozertinib)

Take Zegfrovy (Sunvozertinib) exactly as prescribed by your doctor. It should be taken with food and swallowed whole with water. Do not crush, chew, or break it. Take it at approximately the same time each day and follow your doctor's instructions if you miss a dose or vomit after taking it. Continue treatment for as long as recommended by your healthcare professional.

Zegfrovy (Sunvozertinib) is a targeted EGFR tyrosine kinase inhibitor that blocks abnormal EGFR signaling caused by exon 20 insertion mutations. By inhibiting these signals, it helps reduce the growth and survival of cancer cells, slowing the progression of EGFR exon 20 insertion-positive non-small cell lung cancer (NSCLC).

• Store Zegfrovy tablets at room temperature between 20°C and 25°C.
• Temperature excursions between 15°C and 30°C are permitted.
• Keep the tablets in their original container or packaging until use.
• Keep the medicine out of the reach of children.

Alcohol CONSULT YOUR DOCTOR

Limit or avoid alcohol during treatment, as it may worsen side effects such as nausea, dizziness, or fatigue. Consult your doctor for personalized advice.

Pregnancy CONSULT YOUR DOCTOR

Zegfrovy (Sunvozertinib) may harm an unborn baby. Women who can become pregnant should use effective contraception during treatment and for the period advised by their doctor.

Breastfeeding CONSULT YOUR DOCTOR

Do not breastfeed during treatment with Zegfrovy (Sunvozertinib) and for the period recommended by your doctor.

Driving CONSULT YOUR DOCTOR

Zegfrovy (Sunvozertinib) may cause fatigue, dizziness, or other effects that can affect alertness. Avoid driving or operating machinery if you feel affected.

Kidney CAUTION

Inform your doctor if you have kidney problems before starting treatment. Your kidney function may be monitored during treatment as advised.

Liver CAUTION

Tell your doctor about any liver problems before starting treatment. Liver function should be monitored regularly during treatment.

• Take Zegfrovy (Sunvozertinib) exactly as prescribed and follow the recommended treatment schedule.
• Take it with food and swallow it whole with water without crushing, chewing, or breaking it.
• Stay adequately hydrated and maintain a balanced diet to help manage treatment-related side effects.
• Attend regular medical check-ups and tests to monitor your treatment response and overall health.
• Report severe diarrhea, breathing difficulties, significant skin reactions, or vision changes promptly.
• Read More About - Zegfrovy (Sunvozertinib) from Pharma Five.

Pharma Five, may facilitate the import of Zegfrovy (Sunvozertinib) in small quantities for personal medical use. To proceed with the import process, the applicant is required to submit an application in Form 12A along with a prescription issued by a Registered Medical Practitioner (RMP).

With extensive pharmaceutical industry experience, Pharma Five helps patients access Zegfrovy (Sunvozertinib) through professional import facilitation and related pharmaceutical consultancy services. Pharma Five provides extensive pharmaceutical service coverage across India, serving patients and healthcare requirements in prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.